| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,603 | 22,378 | 22,691 | 40,896 | | Cost of Revenue | 14,553 | 16,018 | 17,251 | 30,151 | | | Gross Profit | 7,050 | 6,360 | 5,440 | 10,745 | | | Operating Expenses | | Research Development | 983 | 309 | (85) | 223 | | Selling General and Administrative | 5,654 | 5,494 | 5,061 | 7,753 | | Non Recurring |
-
|
-
| (626) | 28,513 | | Others | 590 | 582 | 533 | 597 | | | | Total Operating Expenses |
-
|
-
| 4,883 | 37,086 | | | | Operating Income or Loss | (177) | (25) | 557 | (26,341) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (42) | (281) | (1,211) | 1,065 | | Earnings Before Interest And Taxes | (1,212) | (306) | (654) | (25,276) | | Interest Expense | (468) | 468 | 582 | 520 | | Income Before Tax | (744) | (774) | (1,236) | (25,796) | | Income Tax Expense | 227 | 222 | 2,453 | 1,113 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (971) | (996) | (3,689) | (26,909) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (971) | (996) | (3,689) | (26,909) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($971) | ($996) | ($3,689) | ($26,909) |
|
0.01% Nasdaq 
Income Statement
